Advanced Proteome Therapeutics Corporation (APTCF) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Burnaby, BC, カナダ. 現CEOは Benjamin Krantz.
APTCF を有する IPO日 2009-07-10, に上場 Other OTC, 時価総額 $149.63K.
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.
